Oruka Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 43K | 28K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -43K | -28K | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 29.1M | 27.6M | 29.0M | 24.1M | 19.9M | 32.3M | 25.7M | 18.7M |
| Operating Expenses | 36.4M | 34.4M | 34.1M | 28.4M | 25.1M | 38.3M | 29.4M | 21.5M |
| Operating Income | -36.4M | -34.4M | -34.1M | -28.4M | -25.1M | -38.3M | -29.4M | -21.5M |
| Other Income / Gains | 4.6M | 4.8M | 3.8M | 3.9M | 4.1M | 4.9M | 826K | -750K |
| Net Income | -31.8M | -29.6M | -30.3M | -24.6M | -21.0M | -33.4M | -28.6M | -22.2M |
| EPS (Diluted) | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 0 | 5.1M | 4.3M | 5.2M | 5.7M | 3.8M | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 327K | 0 | 0 |
| Selling General And Administrative Expenses | 7.2M | 6.8M | 5.1M | 4.3M | 5.2M | 6.0M | 3.8M | 2.8M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | -0.00 | 0 | 0 |
| Cost And Expenses | 36.4M | 34.4M | 34.1M | 28.4M | 25.1M | 38.3M | 29.4M | 21.5M |
| Interest Income | 4.6M | 4.8M | 3.8M | 3.9M | 4.1M | 4.5M | 1.3M | 444K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 504K | 0 |
| Depreciation And Amortization | 43K | 28K | 20K | 19K | 16K | 18K | 0 | 0 |
| Ebitda | -36.4M | -34.4M | -30.3M | -24.6M | -21.0M | -37.4M | -28.1M | -22.2M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -31.8M | -29.6M | -30.3M | -24.6M | -21.0M | -33.4M | -28.6M | -22.2M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.58 | -0.54 | -0.69 | -0.58 | -0.50 | -1.54 | -1.91 | -1.30 |
| Weighted Average Shs Out | 55.2M | 54.4M | 44.1M | 42.2M | 41.7M | 16.8M | 15.0M | 14.5M |
| Weighted Average Shs Out Dil | 55.2M | 54.4M | 44.1M | 42.2M | 41.7M | 16.8M | 15.0M | 14.5M |